No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.

Webb J., Shah L., Lynch HF.

DOI

10.1080/15265161.2020.1805525

Type

Journal article

Publication Date

2020-09-01T00:00:00+00:00

Volume

20

Pages

W1 - W4

Keywords

Betacoronavirus, Biomedical Research, COVID-19, Coronavirus Infections, Decision Making, Drug Approval, Health Care Rationing, Humans, Pandemics, Pneumonia, Viral, Prior Authorization, SARS-CoV-2, United States, COVID-19 Drug Treatment

Permalink More information Close